Efficacy and Safety of Satralizumab for Thyroid Eye Disease: Week 24 Results from the Phase III SatraGO-1 and SatraGO-2 Randomized Trials

Authors:

Abstract
No abstract available
Funding Information
  • Roche

This publication has 37 references indexed in Scilit: